SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|Date of Report (Date of Earliest Event Reported):||April 25, 2005|
Chicago Mercantile Exchange Holdings Inc.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
|of incorporation)||File Number)||Identification No.)|
|20 South Wacker Drive, Chicago, Illinois||60606|
(Address of principal executive offices)
|Registrants telephone number, including area code:||312-930-1000|
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.
As of April 25, 2005, Chicago Mercantile Exchange Inc. ("CME"), the wholly owned subsidiary of Chicago Mercantile Exchange Holdings Inc. (the "Company"), and The Nasdaq Stock Market, Inc. ("Nasdaq") entered into an amendment (the "Amendment") to that certain License Agreement, effective as of October 9, 2003, between CME and Nasdaq. The Amendment extends the term of the renewal period relating to the exclusive license from October 9, 2011 to October 9, 2012. In addition, the Amendment expands the license to license us the Nasdaq Biotechnology Index for trading futures and options on futures that are based on that index.
A copy of the Amendment will be filed with the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2005.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|Chicago Mercantile Exchange Holdings Inc.|
|April 28, 2005||By:||
Kathleen M. Cronin
|Name: Kathleen M. Cronin|
|Title: Managing Director, General Counsel and Corporate Secretary|